The Embolization Agents Market Size and Growth is anticipated to extent $4,525.75 Million by 2028 from $2,714.82 Million in 2021 to grow at 7.6% CAGR from 2021 to 2028 Driven by rising incidence of tumors and aneurysms and growing prevalence of hypertension, obesity, smoking, and alcoholism; while coil segment to lead the market during forecast period.
New York, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The new research study on the Embolization Agents Market Size and Forecast to 2028 by Product (Coils, Plugs, Beads/Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others) with Impact Assessment of COVID-19 Pandemic and Global Analysis available at https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00025058
Embolization Agents Market: Competitive Landscape and Key Developments
Medtronic; Terumo Corporation; Cook Medical LLC; Boston Scientific Corporation; Abbott; Stryker Corporation; Penumbra, Inc.; Merit Medical Systems Inc.; DePuy Synthes; and KANEKA CORPORATION are among key companies operating in the embolization agents market. Leading players are adopting strategies such as the launch of new product, expansion and diversification of their market presence, and acquisition of new customer base for tapping the prevailing business opportunities.
In July 2021, Terumo Medical Corporation (TMC) launched the AZUR Vascular Plug, the first and only plug compatible with a microcatheter and capable of occluding arteries up to 8mm in diameter. The newest addition to Terumo's extensive embolization portfolio is recommended to use in arteries of the peripheral vasculature to limit or stop blood flow.
Get Exclusive Sample Pages of Embolization Agents Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00025058/
In March 2021, TheraSphereTM Y-90 Glass Microspheres, developed by Boston Scientific Corporation for the treatment of patients suffering from hepatocellular carcinoma (HCC), have been approved by the US Food and Drug Administration (FDA). TheraSphere is now the only radioembolization technology indicated for the treatment of unresectable HCC in the US.
In August 2020, Neuroform Atlas Stent System by Stryker has been authorized by the US Food and Drug Administration (FDA) for an expanded indication, making it the first and only adjunctive stent approved to use in the posterior (rear of the brain) circulation. Long-term treatment is now possible due to the approval of the Neuroform Atlas adjunctive stent for the posterior circulation. This Atlas stent system is used in conjunction with embolic detachable coils.
In 2021, North America dominated the global embolization agents market. The growth in North America is driven by the increasing incidence of neurological disorders, such as stroke and brain aneurysms, and increasing launches of products across the US. For instance, in 2019, MicroVention, Inc. received premarket approval from the FDA for the WEB Aneurysm Embolization System. The WEB System is the first of its kind intrasaccular flow disruptor for aneurysm embolization.
Based on product, the embolization agents market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, and others. The beads/particles segment leads the market, whereas the coils segment is expected to register the highest CAGR during the forecast period. By application, the embolization agents market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. The oncology segment holds the largest share of the embolization agents market and is anticipated to register the highest CAGR in the market during the forecast period. By end user, the embolization agents market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment leads the market and is estimated to register the highest CAGR in the market during the forecast period.
Download Sample PDF Brochure of Embolization Agents Market Size and Growth Research Report at https://www.theinsightpartners.com/sample/TIPRE00025058/
Hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. As per the WHO, in 2021, around 1.13 billion people worldwide have hypertension. It has also mentioned that hypertension is a major cause of premature deaths across the globe. Further, as per Centers for Disease Control and Prevention, in 2018, in the US, approximately half a million deaths were recorded due to hypertension as a primary cause. Additionally, as per the British Heart Foundation, in 2019, about 14.4 million people had high blood pressure in the UK. Furthermore, as per the WHO, in 2016, over 1.9 billion people aged 18 years and above were overweight of which over 650 million adults were obese.
As per Centers for Disease Control and Prevention, during 2017–2018, obesity prevalence in the US was 42.4%. Similarly, as per the NHS 2019, obesity is likely to affect one in every 4 adults. Further, as per the WHO, every year, around six million people die due to tobacco consumption and 2.5 million die due to the harmful alcohol consumption. Thus, the increasing prevalence of hypertension, smoking, alcoholism, and obesity is likely to fuel the demand for embolization agents during the forecast period.
Embolization Agents Market: Segmental Overview
By product, the coil segment is anticipated to register the highest CAGR in the embolization agents market during the forecast period.
Order a Copy of Embolization Agents Market Size, Share, Strategic Insights and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00025058/
Key Questions to Request for Embolization Agents Market:
What are embolization agents?
What are the driving factors for the embolization agents market across the globe?
Who are the developments carrying out by major players in the embolization agents market?
Which region is dominated the embolization agents market?
Which segment is growing at the highest CAGR in the embolization agents market?
Which region is the fastest growing in the embolization agents market?
Browse Related Reports:
Embolization Devices Market For Neurology Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Products (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents); End User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers),and Geography
Embolization Coils Market to 2025 - Global Analysis and Forecasts by Type (Detachable and Pushable Coils), Material (Platinum, Platinum Tungsten Alloy and Platinum & Hydrogel) Application (Neurology, Oncology, Urology, Peripheral Vascular Disease and Cardiology and Others), End User (Hospitals, Ambulatory Surgical Centers and Cardiac Centers) and Geography
Embolization Particle Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product Type (Radioembolization Spheres, Microspheres, Drug Eluting Beads, PVA Particles and Gel Foam Particles, Other Particles); Application (Peripheral Vascular Disease, Neurology, Oncology, Urology, Others); End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Geography
Transcatheter Embolization and Occlusion Devices Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Embolization Coils, Embolization Particles, Liquid Embolics, Flow Diverter Devices, and Accessories), Application (Peripheral Vascular Disease, Urology, Neurology, and Oncology), End User (Hospitals, Ambulatory Surgical Centers and Other End Users), and Geography
Interventional Cardiology Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others); End User (Hospitals, Clinics, Others) and Geography
Interventional Oncology Device Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Ablation Devices, Embolization Device, Support Devices); Procedure (Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Bland Embolization); Cancer Type (Lung cancer, Breast Cancer, Liver Cancer, Kidney Cancer, Prostate Cancer, Others), and Geography
Neurointerventional Devices Market to 2027 - Global Analysis and Forecasts By Type Type (Neurovascular Thrombectomy Devices, Neurovascular Stents, Embolic Protection Devices, Intrasaccular Devices, Embolic Coils, Flow Diverters, Liquid Embolics, Balloons, and Stent Retrievers); Technique (Neurothrombectomy, Stenting, Coiling Procedure, Cerebral Angiography, Flow Disruption); End User (Hospitals, Ambulatory Surgical Centers) and Geography
Interventional Neuroradiology Market to 2027- Global Analysis and Forecasts by Product (Neurovascular Embolization & Coiling Assist Devices, Accessories); Disease (Cerebral Aneurysms, Intra-Cranial Tumors, Acute Strokes, Intra-Cranial Tumors, Others); End User (Hospitals, Ambulatory Surgical Centers, Other End Users) and Geography
Interventional Oncology Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Embolization Devices, Ablation Devices, Support Devices); Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization or Selective Internal Radiation Therapy, Transcatheter Arterial Embolization or Bland Embolization); Cancer Type (Liver Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Other Cancers), and Geography
Interventional Neurology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Aneurysm Coiling and Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices); Application (Artery Stenosis, Ischemic Strokes, Brain Aneurysm, Vein Stenosis, Others) and Geography
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
Press Release - https://www.theinsightpartners.com/pr/embolization-agents-market
Connect With Us on:
RSS/Feeds: https://www.theinsightpartners.com/feed/ | https://www.openpr.com/news/archive/139407/The-Insight-Partners.html